Talphera, Inc.
TLPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427925
No open-market purchases or sales by Talphera, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $29.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Talphera, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Talphera, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hoffman Stephen J | Director | 13,959 | Jun 24, 2026 | 2 |
| Wan Mark A | Director | 13,959 | Jun 24, 2026 | 2 |
| Adams Adrian | Director | 22,709 | Jun 24, 2026 | 2 |
| Broadfoot Jill Marie | Director | 13,647 | Jun 24, 2026 | 2 |
| Todisco Joseph | Director | 11,497 | Jun 24, 2026 | 2 |
| Bozilenko Marina | Director | 14,147 | Jun 24, 2026 | 2 |
| Jain Abhinav | Director | 12,412 | Jun 24, 2026 | 2 |
| Aslam Shakil | Chief Medical Officer | 76,542 | May 21, 2026 | 3 |
| Dasu Badri N | Chief Engineering Officer | 71,440 | Apr 3, 2026 | 2 |
| Asadorian Raffi | Chief Financial Officer | 85,879 | Apr 3, 2026 | 2 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 790,767 | Apr 3, 2026 | 3 |
| Nantahala Capital Management, LLC | 10% Owner, Other: See remarks | 1,992,519Indirect | Mar 17, 2026 | 1 |
| Mack Daniel | 10% Owner, Other: See remarks | 1,992,519Indirect | Mar 17, 2026 | 1 |
| Harkey Wilmot B. | 10% Owner, Other: See remarks | 1,992,519Indirect | Mar 17, 2026 | 1 |
| Palmer Pamela P | Chief Medical Officer | 59,149 | Mar 4, 2024 | 0 |
| Rosen Howard B | Director | 5,293 | Dec 13, 2023 | 0 |
| Afable Richard | Director | 2,468 | Dec 13, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 (view filing) | Mar 13 | 12 daysLate | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +213.3K | $0.59 | +$125.9K | +36.3%800.7K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Aslam ShakilChief Medical Officer | PPurchase | +35.0K | $0.81 | +$28.4K | +72.6%83.2K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +105.4K | $0.81 | +$85.3K | +21.9%587.0K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Asadorian RaffiChief Financial Officer | PPurchaseCommom Stock | +45.0K | $0.81 | +$36.5K | +97.3%91.3K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Dasu Badri NChief Engineering Officer | PPurchase | +35.0K | $0.81 | +$28.4K | +84.9%76.2K after | |
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +213.3K | $0.59 | +$125.9K | +112.0%403.8K after | |
| Feb 26, 2025 (view filing) | Jun 13-14, 2024 | 258 daysLate | Aslam ShakilChief Medical Officer | PPurchase | +5.70K | $1.06 | +$6.03K | +17.8%37.7K after | 2 lots |
| Dec 6, 2024 (view filing) | Dec 5 | 1 day | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +5.00K | $0.64 | +$3.20K | +2.5%208.1K after | |
| Dec 2, 2024 (view filing) | Dec 2 | Same day | Asadorian RaffiChief Financial Officer | SSale | −155 | $0.77 | −$119.35 | −0.4%37.6K after | |
| Dec 2, 2024 (view filing) | Nov 27 | 5 days | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +5.00K | $0.73 | +$3.65K | +2.5%203.1K after | |
| Sep 3, 2024 (view filing) | Aug 30 | 4 days | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +7.26K | $1.05 | +$7.62K | +3.8%198.1K after | |
| Jun 14, 2024 (view filing) | Jun 12-14 | 2 days | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +10.0K | $0.9843 | +$9.84K | +5.9%180.8K after | 3 lots |
| Dec 14, 2023 (view filing) | Dec 13 | 1 day | Angotti Vincent J.Chief Executive Officer | PPurchase | +10.0K | $0.73 | +$7.30K | +10.9%101.8K after | |
| Sep 11, 2023 (view filing) | Sep 11 | Same day | Angotti Vincent J.Chief Executive Officer | PPurchase | +10.0K | $0.80 | +$8.00K | +12.2%91.8K after | |
| Aug 25, 2023 (view filing) | Aug 24-25 | 1 day | Palmer Pamela PChief Medical Officer | SSale | −17.0K | $1.13 | −$19.2K | −35.5%30.8K after | 2 lots |
| Jun 8, 2022 (view filing)4:06 PM ET | Jun 7 | 1 day | Angotti Vincent J.Chief Executive Officer | PPurchase | +46.4K | $0.2227 | +$10.3K | +4.8%1.02M after |